Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 5.12
-0.03 (-0.58%)
Jun 16, 2026, 2:12 PM CET
Genomtec Revenue
Genomtec had revenue of 16.00K PLN in the quarter ending March 31, 2026, with 220.00% growth. This brings the company's revenue in the last twelve months to 30.00K, up 400.00% year-over-year. In the year 2025, Genomtec had annual revenue of 19.00K with 1,800.00% growth.
Revenue (ttm)
30.00K
Revenue Growth
+400.00%
P/S Ratio
2,586.10
Revenue / Employee
937.50
Employees
32
Market Cap
77.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.00K | 18.00K | 1,800.00% |
| Dec 31, 2024 | 1,000.00 | - | - |
| Dec 31, 2023 | 1,000.00 | -39.00K | -97.50% |
| Dec 31, 2022 | 40.00K | -179.00K | -81.74% |
| Dec 31, 2021 | 219.00K | 199.00K | 995.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synektik Spólka Akcyjna | 794.94M |
| Medicalgorithmics | 34.45M |
| Zortrax | 9.06M |
| InventionMed | 3.74M |
| Nestmedic | 1.02M |
| Adiuvo Investments | 1.00M |
| Medinice | 19.00K |
| Milton Essex Spólka Akcyjna | 1.46K |
Genomtec News
- 14 days ago - Genomtec Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Genomtec Annual report: Q4 2025 - Filings
- 7 months ago - Genomtec Quarterly report: Q3 2025 - Filings
- 9 months ago - Genomtec Quarterly report: Q2 2025 - Filings